We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Following the Use of Gel Prosethetics in Breast Reconstruction

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00585884
First Posted: January 3, 2008
Last Update Posted: February 8, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Mentor Worldwide, LLC
Information provided by (Responsible Party):
University of California, Irvine
  Purpose
Following placement of silicone breast prosthetics for reconstruction

Condition
Breast Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Gel-filled Mammary Prostheses in Patients Who Are Undergoing Primary Breast Reconstruction or Revision

Resource links provided by NLM:


Further study details as provided by University of California, Irvine:

Enrollment: 20
Study Start Date: January 2000
Estimated Study Completion Date: January 2025
Estimated Primary Completion Date: January 2025 (Final data collection date for primary outcome measure)
Detailed Description:
Patients undergoing breast reconstruction will be followed for outcomes after placement of silicone prostheses
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women over 18 undergoing breast reconstruction
Criteria

Inclusion Criteria:

  • Women undergoing breast surgery

Exclusion Criteria:

  • Collagen vascular disease, Scleroderma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00585884


Locations
United States, California
The University of California Irvine
Orange, California, United States, 92868
Sponsors and Collaborators
University of California, Irvine
Mentor Worldwide, LLC
Investigators
Study Chair: Jeff Lewis Mentor Worldwide, LLC
  More Information

Responsible Party: University of California, Irvine
ClinicalTrials.gov Identifier: NCT00585884     History of Changes
Other Study ID Numbers: 2000-1383
First Submitted: December 26, 2007
First Posted: January 3, 2008
Last Update Posted: February 8, 2013
Last Verified: February 2013

Keywords provided by University of California, Irvine:
Reconstruction, Silicone prostheses